The EXErcise pRehabilitation Trial (EXERT): A co-design and feasibility study of smartphone delivered exercise prehabilitation in multiple myeloma pre-transplant patients.

Not Applicable

• Conditions: Multiple Myeloma; Cancer - Myeloma

• Registration Number: ACTRN12622001283763
• Lead Sponsor: Deakin University Institute for Physical Activity and Nutrition (IPAN)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-09-30
• Last Update Posted: 18 July 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 9

Inclusion Criteria

Eligible participants will be aged 18+ years; have multiple myeloma (primary diagnosis) and be approaching a stem cell transplant, and can understand and write English as the application is currently only available in english. Medical clearance to participate in exercise will be implied by the referral from their treating team. Participants will need to have access to a smart phone (Android or iOS) and up to 500MB per month of data to operate the app.

Exclusion Criteria

Participants will be excluded if multiple myeloma is not their primary diagnosis and stem cell transplant is not in their course of treatment; if they have neurological compromise due to pathological spinal fractures, or evidence of cognitive impairment or medical instability that would indicate that remotely supervised exercise may not be safe, as deemed by the health-care professional conducting the assessment (Barwon Health).

Study & Design

• Study Type: Interventional
• Study Design: Not specified